Margin squeeze persists; expansion roadmap intact but growth deferred
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Stated 100+ Cr annual PAT; H1 trajectory and YoY margin decline raise doubt on achievement.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Q2 missed on margin (PAT down 28.2% YoY, NPM 9.4%) despite management confidence. Feed cost shock and international price pressure weigh near-term. Capex expansion (₹400 Cr, Sep 28 completion) and SKM Universal merger offer multi-year runway, but execution and macro tailwinds uncertain. Fair-value hold pending H2 margin recovery.
₹189.8 Cr
Revenue · −6% YoY₹17.8 Cr
Reported PAT · −28.2% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Very confident repeating 100+ Cr profitability this year
OVERSTATEDQ2 PAT ₹17.8 Cr; YoY decline 28.2%; H1 combined trajectory flat/weak
Maintained same performance YoY
MISSRevenue down 6%, PAT down 28.2% YoY; QoQ PAT down 25.3%
Feed costs to be mitigated; pursuing soya imports at 10% cheaper
PartialNo timeline given; mitigation uncertain; margin pressure persists
Expansion completing Sep 28 on schedule
METMinor 1–2 week delay reported; 2.4M bird capacity target to be validated
Currently selling 1.5L eggs/day branded, targeting 5L in 2–3 years
METCredible roadmap; no revenue impact this year per prior guidance
Earnings quality
What changed since the last call
Margin pressure intensified
DowngradeFeed costs spiked unexpectedly; PAT ₹17.8 Cr (Q2 FY27) vs ₹24 Cr (Q2 FY26). Mitigation via imports pending.
Capex timeline slipped 1–2 weeks
DowngradeEC rearing house completion delayed; Sep 28 now at risk. First house ready 'in 2 weeks' (from call date Oct 23).
SKM Universal merger accelerated
UpgradeBoard approved merger by April 2027 (prior: standalone ambitions). Adds ₹180 Cr capex, 10K+ ton capacity.
South Korea customer approval achieved
UpgradeTwo customers approved; trial shipment in October; first order expected Q3 FY27.
The Q&A
Analysts pressed on feed cost pass-through, margin recovery timeline, and capex ROI. Management defended via backward integration roadmap and claimed international pricing sets market rates. Light pushback on dividend/cash retention during heavy investment phase.
US supply impact — Meherwan Kotwal
AnsweredUS cheaper but limited impact on Japan/full-length eggs. Average realization ₹700/dozen. Grading operation deferred to next FY.
Branded eggs scale — Meherwan Kotwal
AnsweredCurrent 1.5L/day. Target 5L/day in 2–3 years. Strategy still being brainstormed on segment/price point.
Profitability outlook — Venkatesh
PartialVery confident of 100+ Cr annual PAT. Exploring soya imports at 10% cheaper. Cost structure protected by backward integration.
Gross margin dynamics — Mahesh Atal
AnsweredInternational prices set by Europe/US/Ukraine. No pricing power. Control via efficiency & 2.4M bird expansion by Sep 28.
Expansion progress — Murugeason
AnsweredSouth Korea approved; first order expected Oct–Dec. EC farm Sep 28 completion (minor delay from target).
Feed sourcing strategy — Saurabh Dole
AnsweredMultiple suppliers, inventory 1–15 days. Considering soya import at ₹10–15% cheaper. No single-supplier risk.
SKM Universal roadmap — Venkatesh
PartialMerger by April 2027. Capacity ₹7K→₹10K+ tons. Investment ₹180–250 Cr. Aggressive growth from FY28. No annual targets (too variable).
UMC goodwill — Madhur Rathi
AnsweredPurchase of shares from sister company (SKM Universal) for merger. Not operating goodwill; one-time acquisition cost.
Cash deployment — Soham
AnsweredSeasonal business requires ₹100 Cr cash buffer. Debt cheaper (3% subsidy + 5–6% interest). Earn >5% from cash; optimize WACC.
Expansion capex ROI — Meherwan Kotwal
Partial₹180 Cr capex + ₹150 Cr term loan (8.25% with subsidy). Margin 30 Cr. Full benefit Sep 28 onwards. Gradual cost reduction as capacity ramps.
Guidance
No numeric FY27 guidance; aspirational 100+ Cr PAT
LowManagement cited SEBI rules and market volatility. Prior year guidance: growth price-led, no volume growth expected.
100+ Cr PAT reaffirmed despite Q2 pressure
LowH1 trajectory weak; H2 needs feed cost mitigation + Sep 28 capex benefits to reach target. Management hedged heavily.
₹400 Cr expansion capex (approved); ₹300 Cr term loan signed, ₹100 Cr Access Bank
HighEC farm Sep 28 completion; dry powder 10K ton expansion. Board + lenders locked in.
Risks the call surfaced
Feed cost inflation
HighSoya price surge 'sudden' and unexpected; ₹10 Cr+ impact in Q2. Mitigation (imports) lacks clear timeline.
International price volatility
HighEgg prices set by Europe/US/Ukraine supply; Indian producer is price-taker. US oversupply pressuring ₹700/dozen realization.
Capex execution & integration
MediumEC farm running 1–2 weeks behind Sep 28 target. SKM Universal merger (Apr 2027) adds execution complexity. ₹400 Cr spend over 2 years.
Customer concentration
MediumLarge export volumes to Japan; diversification ongoing (South Korea approved). Domestic branded eggs still nascent (₹1.5L/day).
Leverage during investment phase
Medium₹300 Cr term loan + ₹100 Cr Access Bank debt during ₹400 Cr capex spend. PAT under pressure. Total debt ~₹450 Cr per management.
Management
Score 6/10. Transparent on costs/delays but evasive on numeric guidance (SEBI rules cited). Candid on feed cost shock; forward-looking on capex roadmap. Prior capex (₹400 Cr) on track but minor slippage (1–2 weeks). Branded eggs delayed to FY28. SKM Universal merger accelerated.
1 · Sep 28, 2026
EC expansion farm full commissioning; 2.4M bird capacity online
2 · Oct–Dec 2026
South Korea first order expected (approved sample); new market revenue
3 · Apr 2027
SKM Universal merger closure; scaled export platform
Fair-value hold pending H2 margin recovery.
Informational and educational content only. Not investment advice.